PMC:7558233 / 27374-27555 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"666","span":{"begin":0,"end":19},"obj":"Chemical"},{"id":"670","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"671","span":{"begin":142,"end":161},"obj":"Disease"}],"attributes":[{"id":"A666","pred":"tao:has_database_id","subj":"666","obj":"MESH:C558899"},{"id":"A670","pred":"tao:has_database_id","subj":"670","obj":"MESH:C000657245"},{"id":"A671","pred":"tao:has_database_id","subj":"671","obj":"MESH:D017093"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Lopinavir–ritonavir Severe COVID-19 Probable No significant acceleration in the time to clinical improvement Gastrointestinal tract symptoms; impairment of liver and kidney function"}

{"project":"LitCovid-sentences","denotations":[{"id":"T159","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Lopinavir–ritonavir Severe COVID-19 Probable No significant acceleration in the time to clinical improvement Gastrointestinal tract symptoms; impairment of liver and kidney function"}